{"text": ["Key", "Takeaways", "from", "Eli", "Lilly's", "(LLY)", "Q4", "Earnings", "Report"], "created_at": "2019-02-13 22:37:57"}
{"text": ["Key", "Takeaways", "from", "Eli", "Lilly's", "(LLY)", "Q4", "Earnings", "Report"], "created_at": "2019-02-13 22:37:57"}
{"text": ["Conatus", "(CNAT)", "Completes", "Enrollment", "in", "Phase", "II", "NASH", "Study"], "created_at": "2019-02-13 22:37:03"}
{"text": ["Conatus", "(CNAT)", "Completes", "Enrollment", "in", "Phase", "II", "NASH", "Study"], "created_at": "2019-02-13 22:37:03"}
{"text": ["Top", "Research", "Reports", "for", "ExxonMobil,", "Merck", "&", "Danaher"], "created_at": "2019-02-13 21:38:24"}
{"text": ["Top", "Research", "Reports", "for", "ExxonMobil,", "Merck", "&", "Danaher"], "created_at": "2019-02-13 21:38:24"}
{"text": ["Conatus", "(CNAT)", "Completes", "Enrollment", "in", "Phase", "II", "NASH", "Study"], "created_at": "2019-02-13 20:36:08"}
{"text": ["Key", "Takeaways", "from", "Eli", "Lilly's", "(LLY)", "Q4", "Earnings", "Report"], "created_at": "2019-02-13 20:07:08"}
{"text": ["Clinigen", "agrees", "to", "buy", "U.S.", "rights", "to", "Novartis'", "cancer", "drug", "Proleukin"], "created_at": "2019-02-13 18:53:33"}
{"text": ["Top", "Research", "Reports", "for", "ExxonMobil,", "Merck", "&", "Danaher"], "created_at": "2019-02-13 18:37:06"}
{"text": ["Aduro", "Initiates", "Dosing", "in", "Phase", "I", "Melanoma", "Study", "on", "ADU-S100"], "created_at": "2019-02-13 01:37:18"}
{"text": ["Aduro", "Initiates", "Dosing", "in", "Phase", "I", "Melanoma", "Study", "on", "ADU-S100"], "created_at": "2019-02-13 01:37:18"}
